Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT
A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 198 participants.
Also called NCT03686696
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 198 participants
- Sponsor
- Registry
-
NCT03686696
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Australia, New Zealand, Norway, Spain, Sweden
- Registry status
- Terminated
Technical summary
Registry record NCT03686696. Randomized; no masking; primary purpose treatment. Start 2018-12-16 (actual); primary completion 2023-05-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT
- Acronym
- MINOCA-BAT
- Condition
- Myocardial Infarction With Non-obstructive Coronary Arteries
- Intervention (Drug)
- Beta blocker
- Intervention (Drug)
- ACEI
- Intervention (Drug)
- ARB
- Lead sponsor
- Uppsala University
- Collaborator
- Karolinska Institutet
- Collaborator
- Göteborg University
- Collaborator
- University of Leeds
- Collaborator
- University of Adelaide
- Collaborator
- Oslo University Hospital
- Collaborator
- New York University
Record details
- Record id
cardio:ct-nct03686696- Content hash
fd3740e693c6b34448a80be687ddef999e402e4876fdcf0d98c8214a89a91fe1